Stockscreener 앱 받기
2.57
22.38%
0.47
시간 외 거래:
2.56
-0.010
-0.39%
전일 마감가:
$2.10
열려 있는:
$2.23
하루 거래량:
3.13M
Relative Volume:
25.13
시가총액:
$9.84M
수익:
-
순이익/손실:
$-28.71M
주가수익비율:
-0.2505
EPS:
-10.2587
순현금흐름:
$-8.77M
1주 성능:
-28.41%
1개월 성능:
-29.59%
6개월 성능:
-70.17%
1년 성능:
+13.22%
1일 변동 폭
$2.11
$3.20
1주일 범위
$2.07
$3.75
52주 변동 폭
$2.07
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
2.56 | 8.07M | 0 | -28.71M | -8.77M | -10.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.04 | 125.08B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 81.90B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
708.88 | 45.06B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.23 | 42.50B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
285.44 | 33.16B | 5.36B | 287.73M | 924.18M | 2.5229 |
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Quantum BioPharma Provides Corporate Update - The Manila Times
Quantum BioPharma Ltd. Revises Terms of Debenture Units Following Market Price Decrease - Quiver Quantitative
Quantum BioPharma Provides Corporate Update - GlobeNewswire Inc.
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results - TipRanks
Trade Recap: Will Quantum BioPharma Ltd outperform during market rallies2026 Pullback Review & Consistent Income Trade Recommendations - baoquankhu1.vn
Quantum BioPharma Ltd. announced that it expects to receive CAD 4 million in funding - marketscreener.com
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - Shelby Star
Aug PostEarnings: Whats the fair value of Quantum BioPharma Ltd stockVolume Spike & Weekly Setup with ROI Potential - baoquankhu1.vn
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
A | What’s the fair value of Quantum BioPharma Ltd. stockM&A Rumor & Consistent Profit Alerts - mfd.ru
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - PR Newswire
Entry Recap: Should I hold or sell Quantum BioPharma Ltd nowTrade Volume Report & Technical Pattern Alert System - baoquankhu1.vn
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors - marketscreener.com
Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors - GlobeNewswire
QNTM PE Ratio & Valuation, Is QNTM Overvalued - Intellectia AI
FinancialContentCONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - FinancialContent
User - The Chronicle-Journal
Quantum Biopharma Ltd. Class Action Notice for Investors - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors - GlobeNewswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - Prime Publishers, Inc.
Quantum Biopharma Shareholders File Class Action Lawsuit - Intellectia AI
Targets Report: Will Quantum BioPharma Ltd stock benefit from M A2025 Bull vs Bear & Free Community Consensus Stock Picks - baoquankhu1.vn
Will Quantum BioPharma Ltd stock benefit from M AMarket Trend Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quantum Biopharma Ltd. Class Action Alert for Investors - intellectia.ai
Quantum Biopharma Reports Q3 2025 Financial Results - MSN
QNTM Stockholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
Risk Recap: Will QNTM stock go up in YEARJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
QNTM Shareholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM Investors Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum Biopharma Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud - intellectia.ai
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Quantum Biopharma Ltd (QNTM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.42%
0.24%
자본화:
|
볼륨(24시간):